Patch for targeted delivery of an oncogenic cargo to a tissue

Patent metadata

Field	Value
Publication number	US-2025127729-A1
Application number	US-202318835464-A
Country	US
Kind code	A1
Filing date	Feb 1, 2023
Priority date	Feb 3, 2022
Publication date	Apr 24, 2025
Grant date	—

Abstract

Patches configured to hold an oncogenic cargo and deliver the cargo in a controlled manner to a predetermined location of a specified tissue are disclosed. As one example, a patch can comprise a base layer configured to adhere to a predetermined location of a tissue and a hydrogel layer. The hydrogel layer can comprise a plurality of microchannels that are configured to store and release a gene-modifying vector over a time period and in a quantity sufficient to produce a somatic cell tumor through manipulation of the genome of somatic cells at the predetermined location.

First claim

1 . A patch, comprising:
a base layer configured to adhere to a predetermined location of a tissue; and a hydrogel layer comprising a plurality of microchannels that are configured to store and release a gene-modifying vector over a time period and in a quantity sufficient to produce a somatic cell tumor through manipulation of the genome of somatic cells at the predetermined location.

2 . (canceled)

3 . (canceled)

4 . The patch of claim 1 , wherein the hydrogel layer further comprises the gene-modifying vector, and wherein the gene-modifying vector comprises an oncogenic viral vector disposed within lumina of the microchannels.

5 . The patch of claim 1 , wherein the hydrogel layer further comprises the gene-modifying vector, and wherein the gene-modifying vector comprises an adenoviral vector expressing Cre recombinase (AdCre) disposed within lumina of the microchannels.

6 . The patch of claim 4 , wherein the gene-modifying vector is carried within oncogenic nanoparticles disposed within lumina of the microchannels.

7 . The patch of claim 1 , wherein the microchannels of the plurality of microchannels are anisotropically aligned with one another in a hydrogel of the hydrogel layer.

8 . The patch of claim 1 , wherein the cargo layer of the patch comprises an alginate and divalent hydrazide group cross-linked hydrogel.

9 . The patch of claim 1 , wherein a diameter of the plurality of microchannels is in a range of 50-1000 μm.

10 . The patch of claim 1 , wherein a thickness of the patch is in a range of 0.05-1.5 mm, wherein a length of the patch is in a range of 1-10 mm, and wherein a width of the patch is in a range of 1-10 mm.

11 . A method for the production of a somatic-cell tumor at a predetermined location of a tissue, comprising:
positioning, at the predetermined location, a patch comprising a base layer configured to adhere to the predetermined location and a hydrogel layer comprising a plurality of microchannels containing a releasable oncogenic cargo stored within the plurality of microchannels, such that the oncogenic cargo is released from the hydrogel layer and produces a somatic-cell tumor at the predetermined location through manipulation of the genome of the somatic cells.

12 .- 15 . (canceled)

16 . The method of claim 11 , wherein the patch is configured to flex and be positioned against one of a luminal surface or exterior surface of the tissue.

17 . The method of claim 11 , wherein positioning the patch at the predetermined location of the tissue includes adhering the base layer of the patch to a luminal surface or exterior surface of the tissue.

18 . (canceled)

19 . The method of claim 11 , further comprising, prior to the positioning the patch at the predetermined location of the tissue, folding the patch into a folded delivery state and inserting it into an inner lumen of a delivery apparatus, and further comprising navigating the delivery apparatus toward the predetermined location of the tissue.

20 . (canceled)

21 . (canceled)

22 . The method of claim 19 , wherein positioning the patch at the predetermined location of the tissue includes pushing the folded patch out of a distal end portion of the delivery apparatus at the predetermined location of the tissue and unfolding the patch from the folded delivery state to an unfolded state such that the base layer is positioned against a surface of the predetermined location of the tissue.

23 . The method of claim 11 , further comprising, after positioning the patch at the predetermined location of the tissue, automatically degrading the patch at the predetermined location of the tissue over a predetermined length of time.

24 . The method of claim 23 , wherein the predetermined length of time is in a range of three to five weeks.

25 .- 32 . (canceled)

33 . A method of making the patch of claim 1 , comprising:
forming a hydrogel by cross-linking gel-forming molecules in a cross-linking solution; adhering a base layer on a surface of the hydrogel, the base layer configured to adhere to a tissue; lyophilizing the hydrogel under conditions sufficient to generate a plurality of microchannels such that a cryogel with the plurality of microchannels is formed; and rehydrating the cryogel in a solution containing a selected cargo.

34 . The method of claim 33 , wherein the selected cargo is an oncogenic viral vector.

35 .- 37 . (canceled)

38 . The method of claim 33 , wherein the generated microchannels of the plurality of microchannels are anisotropically aligned with one another in the hydrogel.

39 .- 41 . (canceled)

42 . A method of making the patch of claim 1 , comprising:
mixing a flexible cross-linked hydrogel with a solution comprising a cargo; lyophilizing the flexible cross-linked hydrogel and cargo under conditions sufficient to generate a plurality of microchannels comprising the cargo in the hydrogel; and adhering a base layer on a surface of the hydrogel, the base layer configured to adhere to a tissue.

43 .- 47 . (canceled)

48 . The method of claim 42 , wherein the hydrogel is an alginate and divalent hydrazide group cross-linked hydrogel.

49 . (canceled)

50 . (canceled)

Assignees

• Univ Illinois

Inventors

• Kong Hyunjoon
• Kim Byoungsoo
• Schook Lawrence B
• Schachtschneider Kyle
• Elkhadragy Lobna
• Carlino Maximillian

Classifications

• A61K48/0008

  characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition · CPC title

• A61K9/0024 Primary

  Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue (compositions for intravenous administration, normal injectable solutions or dispersions for, e.g. subcutaneous administration A61K9/0019; brain implants A61K9/0085; (coated) prostheses, catheters or stents A61L) · CPC title

• A61K48/005

  characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered · CPC title

• C12N15/90

  Stable introduction of foreign DNA into chromosome · CPC title

• C12N2740/16043

  viral genome or elements thereof as genetic vector · CPC title